G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease

被引:29
作者
Althoff, Till F. [1 ,2 ]
Offermanns, Stefan [3 ,4 ]
机构
[1] Charite, Charite Campus Mitte, Dept Cardiol & Vasc Med, D-10117 Berlin, Germany
[2] Charite, Charite Campus Mitte, Ctr Cardiovasc Res, D-10117 Berlin, Germany
[3] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany
[4] Goethe Univ Frankfurt, Fac Med, D-60590 Frankfurt, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2015年 / 93卷 / 09期
关键词
Vascular smooth muscle cells; G-protein-coupled receptors; G-protein signaling; THROMBIN RECEPTOR EXPRESSION; NUCLEOTIDE EXCHANGE FACTOR; NEOINTIMA FORMATION; ANGIOTENSIN-II; MYOSIN PHOSPHATASE; THROMBOXANE A(2); DIFFERENTIATION; PROLIFERATION; RHO; ACTIVATION;
D O I
10.1007/s00109-015-1305-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Differentiated vascular smooth muscle cells (VSMCs) are critical determinants of vascular tone and blood pressure. However, during vascular remodeling processes, which occur in response to changing hemodynamics or vascular injury, VSMCs lose most of their contractile functions in a dedifferentiation process, which goes along with cell proliferation and cell migration. VSMCs are under the constant control of a variety of mediators with vasocontractile or vasodilatory properties. Most of these mediators act through G-protein-coupled receptors, which, via different downstream signaling pathways, regulate the phosphorylation of myosin light chain and thereby control vascular tone. Recent work indicates that procontractile G-protein-mediated signal transduction pathways are also critical regulators of vascular smooth muscle dedifferentiation and redifferentiation. This review describes some of the key G-protein-mediated signal transduction pathways regulating vascular tone and VSMC differentiation and their involvement in cardiovascular diseases.
引用
收藏
页码:973 / 981
页数:9
相关论文
共 74 条
  • [1] Expression profiling identifies smooth muscle cell diversity within human intima and plaque fibrous cap loss of RGS5 distinguishes the cap
    Adams, LD
    Geary, RL
    Li, J
    Rossini, A
    Schwartz, SM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (02) : 319 - 325
  • [2] Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites
    Alewijnse, AE
    Peters, SLM
    Michel, MC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (06) : 666 - 684
  • [3] Epigenetic Control of Smooth Muscle Cell Differentiation and Phenotypic Switching in Vascular Development and Disease
    Alexander, Matthew R.
    Owens, Gary K.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 74, 2012, 74 : 13 - 40
  • [4] Procontractile G protein-mediated signaling pathways antagonistically regulate smooth muscle differentiation in vascular remodeling
    Althoff, Till F.
    Juarez, Julian Albarran
    Troidl, Kerstin
    Tang, Cong
    Wang, Shengpeng
    Wirth, Angela
    Takefuji, Mikito
    Wettschureck, Nina
    Offermanns, Stefan
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (12) : 2277 - 2290
  • [5] Ca2+-independent, inhibitory effects of cyclic adenosine 5′-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase c2α, Rho, and myosin phosphatase in vascular smooth muscle
    Azam, Mohammed Ali
    Yoshioka, Kazuaki
    Ohkura, Shinsuke
    Takuwa, Noriko
    Sugimoto, Naotoshi
    Sato, Koichi
    Takuwa, Yoh
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (02) : 907 - 916
  • [6] Activation of IP and EP3 receptors alters cAMP-dependent cell migration
    Blindt, R
    Bosserhoff, AK
    Dahl, RV
    Hanrath, P
    Schör, K
    Hohlfeld, T
    Meyer-Kirchrath, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 444 (1-2) : 31 - 37
  • [7] Leukemia-associated Rho guanine nucleotide exchange factor promotes Gαq-coupled activation of RhoA
    Booden, MA
    Siderovski, DP
    Der, CJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (12) : 4053 - 4061
  • [8] Burdyga T., 2012, Muscle, P1155, DOI [10.1016/B978-0-12-381510-1.00086-7, DOI 10.1016/B978-0-12-381510-1.00086-7]
  • [9] Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR
    Cheng, Yunhui
    Makarova, Natalia
    Tsukahara, Ryoko
    Guo, Huazhang
    Shuyu, E.
    Farrar, Patricia
    Balazs, Louisa
    Zhang, Chunxiang
    Tigyi, Gabor
    [J]. CELLULAR SIGNALLING, 2009, 21 (12) : 1874 - 1884
  • [10] Sphingosine 1-Phosphate A Regulator of Arterial Lesions
    Daum, G.
    Grabski, A.
    Reidy, M. A.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (10) : 1439 - 1443